6,678 trials
Calcium and Vitamin D Deficiencies
Primary: Percentage of Participants With a Preference for Each Treatment Within Each Test Group — 67.2; 72.3; 61.8; 52.9 percentage of participants
Minor Procedural Pain
Primary: Safety and Tolerability as Measured by the Number of Adverse Events — 0 adverse events
Primary Brain Tumor
Primary: Percentage of Patients With Overall Lesion Visualization and Characterization Scored as Good or Excellent — 94.0; 96.2; 93.2; 90.6 percentage of patients
Hepatic Failure · Hepatic Impairment · Chronic Hepatitis C Infection With Hepatic Coma
Primary: Area Under the Concentration-time Curve From Time Zero to Time of Last Measurable Concentration (AUC0-last) of Buprenorphine, Norbuprenorphine, Naloxone and…
Depression · Anxiety
Primary: C-Reactive Protein at 12 Weeks — 3.31; 0.50 mg/L — p=.001
Postmenopausal Osteoporosis
Primary: Percentage of Participants With Adherence to Treatment — 98.5; 98.6 percentage of participants
Hepatitis B, Chronic
Primary: Number of Hepatitis B Envelope Antigen (HBeAg) Positive Participants With Hepatitis B Virus Deoxyribonucleic Acid (HBV-DNA) Less Than (<) 1,00,000 Copies Per Milliliter…
Diabetes · Atherosclerosis
Primary: Brachial Artery Flow Mediated Dilation — 5.2; 5.6; 5.6; 6.3 %FMD — p=<0.05
Hepatitis C, Chronic
Primary: SVR12 (Sustain Virological Response, HCV RNA Undetectable 12 Weeks Post-treatment) — 71; 100; 100 percentage of participants
Influenza
Primary: Number of Participants Reporting Solicited Injection-Site and Solicited Systemic Reactions Following Vaccination With the 2015-2016 Formulation of Fluzone® Quadrivalent…
Premenstrual Dysphoric Disorder
Primary: Premenstrual Tension Scale (PMTS) — 22.3; 21.4; 15.6; 16.8 units on a scale — p=0.21
Influenza
Primary: Number of Subjects Shedding Vaccine Virus of Each Subtype by PCR — 1; 6; 9; 1 participants
Hereditary Angioedema
Primary: Time to Complete or Near Complete Resolution From Onset of Symptoms — 735; 377 minutes
Head and Neck Neoplasms
Primary: Opreation Duration — 97.1; 116.3 minutes — p=0.022
Prostate Hypertrophy · Renal Disease
Primary: Surgical Rating Scale — 4; 4.7 units on a scale (1-5) — p=<0.001